Table 1.
Summary table | |
---|---|
Demographics | |
Total number of patients | 81 |
Total number of ureteroscopy procedures | 102 |
Male: female ratio | 1:1.1 |
Mean age | 8.8 years (range 1.5–16 years) |
Stone attributes | |
Mean single stone size | 9.2 mm (range 3–30 mm) |
Mean cumulative stone size | 11.5 mm (range 4–46 mm) |
Stone location |
Upper pole—8.8% Mid pole—12.7% Lower pole—35.4% Renal pelvis—16.5% Upper ureter—5.1% Mid ureter—6.3% Distal ureter—15.2% |
Multiple stones | 22/81 (27%) |
Pre-operative positive urine culture | 15/102 (14%) |
Pre-operative stent | 35/102 (34%) |
Post-operative stent | 61/102 (60%) |
Access sheath use | 21/102 (20.5%) |
Results | |
Initial stone free rate | 73% |
Final stone free rate | 99% |
Number of URS procedures/patient for being stone free (excluding 7 diagnostic URS cases) |
1.28 (range 1–3) 54—1 procedure 19—2 procedures 1—3 procedures |
Stone analysis available in 52/81 (61.7%) patients | |
Calcium oxalate | 13 |
Calcium phosphate | 12 |
Magnesium ammonium phosphate (MAP) | 10 |
Calcium oxalate and calcium phosphate | 8 |
Calcium phosphate and MAP | 5 |
Cystine | 3 |
Uric acid | 1 |
Length of stay | 1.2 days (range 1–5 days) |
Complication rate | 3% |
Re-admission rate | 0.9% |